Kevin Cognetti
About Kevin Cognetti
Kevin Cognetti is a corporate strategy professional with extensive experience in the pharmaceutical industry. He holds a JD/MBA from Georgetown University and has held leadership roles at Pfizer and McKinsey & Company, currently serving as Head of Corporate Strategy at Kite Pharma.
Work at Kite Pharma
Kevin Cognetti has been serving as the Head of Corporate Strategy at Kite Pharma since 2020. In this role, he is responsible for guiding the company's strategic direction and initiatives. Kite Pharma is known for its focus on innovative cancer therapies, particularly in the field of cell therapy. Cognetti's leadership contributes to the company's efforts in advancing its corporate strategy to enhance its market position and drive growth.
Previous Experience at Pfizer
Prior to his current role, Kevin Cognetti held several positions at Pfizer. He worked as the Head of Strategy from 2019 to 2020, where he focused on strategic planning and execution. Before that, he served as Director from 2013 to 2014 and as Director - Team Lead from 2014 to 2016. His tenure at Pfizer culminated in his role as Sr. Director for North America and AfME from 2016 to 2019, where he oversaw various strategic initiatives.
Experience at McKinsey & Company
Kevin Cognetti worked as an Engagement Manager at McKinsey & Company from 2008 to 2012. In this capacity, he provided strategic consulting services to clients, helping them address complex business challenges. His experience at McKinsey equipped him with valuable insights into corporate strategy and operational efficiency, which he later applied in his roles at Pfizer and Kite Pharma.
Education and Expertise
Kevin Cognetti earned a JD/MBA from Georgetown University, completing his studies from 2003 to 2007. He also holds a Bachelor of Arts in Political Science and Government from the same institution, which he obtained from 1998 to 2002. His educational background provides him with a strong foundation in both legal and business principles, enhancing his expertise in corporate strategy.